It’s the latest action targeting PBMs for allegedly using their market power to raise drug prices, and comes as the Federal Trade Commission also launched a similar investigation.
It’s the latest action targeting PBMs for allegedly using their market power to raise drug prices, and comes as the Federal Trade Commission also launched a similar investigation.